Product Images Cisplatin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Cisplatin NDC 60505-6279 by Apotex Corp., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Cisplatin Injection,USP 50 mg/50 mL vial label - image 02
![image-02.jpg Cisplatin Injection,USP 50 mg/50 mL vial label - image 02](https://ndclist.com/assets/spl/images/8d170f6f-37d7-41ce-aae2-33307a6ef3ae/400x-image-02.jpg)
This is a description of Cisplatin, a cytotoxic agent used for intravenous use in the treatment of cancer. The medication is provided in a sterile solution containing cisplatin and sodium chloride. It is typically administered once every 3 to 4 weeks, with dosages rarely exceeding 100 mg/m². The accompanying insert contains detailed information on indications, dosage, directions for use, and precautions. It is important to store the medication at room temperature and protect it from light. The manufacturer is QILU Pharmaceutical Co., Ltd. in China, and the medication is distributed by Apotex Corp. in the USA.*
Cisplatin Injection, USP 50 mg/50 mL carton label - image 03
![image-03.jpg Cisplatin Injection, USP 50 mg/50 mL carton label - image 03](https://ndclist.com/assets/spl/images/8d170f6f-37d7-41ce-aae2-33307a6ef3ae/400x-image-03.jpg)
This text appears to be a label or information sheet for the drug Cisplatin, an anti-cancer medication used for intravenous administration. It contains details about the drug name, dosage, storage instructions, manufacturer information, and a caution about cytotoxic properties. The document emphasizes the importance of reading the enclosed insert for detailed indications, dosage, directions for use, and precautions. It also mentions that Cisplatin doses greater than 100 mg every 3-4 weeks are rarely used and advises not to refrigerate the medication. The text provides specific storage conditions, such as storing at controlled room temperature and protecting it from light. It also includes information about the sterile solution for intravenous use and the manufacturer's details.*
safety stickers enclosed to Cisplatin Injection, USP 50 mg/50 mL carton - image 04
![image-04.jpg safety stickers enclosed to Cisplatin Injection, USP 50 mg/50 mL carton - image 04](https://ndclist.com/assets/spl/images/8d170f6f-37d7-41ce-aae2-33307a6ef3ae/400x-image-04.jpg)
This document provides detailed instructions for the proper handling and labeling of Clisplatin injections. It outlines the process of adhering safety stickers to the drug container and how pharmacists should record the total dose of the medication. The stickers are meant to track the medication from the pharmacy to administration to the patient, ensuring accurate dosing and safe medication practices. These safety measures can help prevent errors and improve patient care.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.